David J. Arthur, Chief Executive Officer at Salarius Pharmaceuticals, Inc. (SLRX), bought 278,976 shares at $0.39 ($109K) on 2022-03-03, disclosed to the SEC on 2022-03-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.39 | 139,488 | $54K | 50.0% |
| 2 | $0.39 | 139,488 | $54K | 50.0% |
| Total | $0.39 avg | 278,976 | $109K | 100% |
| Filing → |
| SLRX | BUY | 2020-08-20 | $1K | — | Filing → |
| SLRX | BUY | 2020-02-12 | $3K | — | Filing → |